To the content
2 . 2021

Expert council "Science and practice in the field of probiotics application in obstetrics and gynecology"

Abstract

From 8 to 23 April 2021 under co-chairmanship of Vice-President of the Russian Society of Obstetricians and Gynaecologists (RSOG), Head of the Scientific and Educational Programs Division of the Scientific-Organizing Department of the V.I. Kulakov Obstetrics, Gynecology and Perinatology National Medical Research Center of Ministry of Health^re of the Russian Federation (Moscow), Professor I.I. Baranov and Leading Researcher of the Reproductology Department of the Research Institute of Obstetrics and Gynecology named after D.O. Ott (St. Petersburg), Professor N.I. Tapilskaya an online meeting of the Expert council "Science and practice in the field of probiotics application in obstetrics and gynecology" was held. The Council of Experts was attended by 34 people representing 28 universities and 19 Russian cities, including 26 professors and doctors of science, 8 candidates of science (see Appendix). Among them were obstetrician-gynecologists, nutritionists, gastroenterologists, clinical pharmacologists, medical microbiologists who worked according to the established program: a meeting of the expert council, which took place within the 61 Regional Educational School of the RSOG in St. Petersburg on April 8-9, 2021, and then through personal accounts online. As a result, it became possible to prepare the presented final document, which reflects the opinion of experts on various aspects of the problem under discussion, and to formulate proposals of experts.

Keywords:obstetrics, gynecology, probiotics, expert council, Russian Society of Obstetricians and Gynaecologists

For citation: Expert council "Science and practice in the field of probiotics application in obstetrics and gynecology". Akusherstvo i ginekologiya: novosti, mneniya, obuchenie [Obstetrics and Gynecology: News, Opinions, Training]. 2021; 9 (2): 68-81. DOI: https://doi.org/10.33029/2303-9698-2021-9-2-68-81 (in Russian)

References

1. Agarwal S.K., et al. Application of the estrogen threshold hypothesis to the physiologic hypoestrogenemia of lactation. Breastfeed Med. 2015; 10 (2): 77-83.

2. Al-Ghazzewi F.H., Tester R.F. Biotherapeutic agents and vaginal health. J Appl Microbiol. 2016; 121 (1): 18-27.

3. Amabebe E., et al. Microbial dysbiosis-induced obesity: role of gut microbiota in ho-moeostasis of energy metabolism. Br J Nutr. 2020; 123 (10): 1127-37.

4. Amabebe E., Anumba D.O.C. The vaginal microenvironment: the physiologic role of Lactobacilli. Front Med. 2018; 5: 181.

5. Amabebe E., Anumba D.O.C. Female gut and genital tract microbiota-induced crosstalk and differential effects of short-chain fatty acids on immune sequelae. Front Immunol. 2020; 11: 2184.

6. Anukam K.C., et al. Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes Infect. 2006; 8 (12-13): 2772-6.

7. Anukam K.C., et al. Yogurt containing probiotic Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 helps resolve moderate diarrhea and increases CD4 count in HIV/AIDS patients. J Clin Gastroenterol. 2008; 42 (3): 239-43.

8. Anukam K.C., et al. Probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 may help downregulate TNF-alpha, IL-6, IL-8, IL-10 and IL-12 (p70) in the neurogenic bladder of spinal cord injured patient with urinary tract infections: a two-case study. Adv Urol. 2009; 2009: 680363.

9. Barthow C., et al. The Probiotics in Pregnancy Study (PiP Study): rationale and design of a double-blind randomised controlled trial to improve maternal health during pregnancy and prevent infant eczema and allergy. BMC Pregnancy Childb. 2016; 16 (1): 133.

10. Beerepoot M.A.J., et al. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women. Arch Intern Med. 2012; 172 (9): 704-12.

11. Belkaid Y., Hand T.W. Role of the microbiota in immunity and inflammation. Cell. 2014; 157 (1): 121-41.

12. Biagi E., et al. Ageing of the human metaorganism: the microbial counterpart. Age. 2012; 34 (1): 247-67.

13. Bliss E.S., Whiteside E. The gut-brain axis, the human gut microbiota and their integration in the development of obesity. Front Physiol. 2018; 9: 900.

14. Bohbot J.M., Cardot J.M. Vaginal impact of the oral administration of total freeze-dried culture of LCR 35 in healthy women. Infect Dis Obstet Gynecol. 2012; 2012: 503648.

15. Boulange C.L., et al. Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med. 2016; 8 (1): 42.

16. Brocklehurst P., et al. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev. 2013; 1: CD000262.

17. Brotman R.M., et al. Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy. Menopause. 2018; 25 (11): 1321-30.

18. Brusselaers N., et al. Vaginal dysbiosis and the risk of human papillomavirus and cervical cancer: systematic review and meta-analysis. Am J Obstet Gynecol. 2019; 221 (1): 9-18.e8.

19. Carda-Dieguez M., et al. Variations in vaginal, penile, and oral microbiota after sexual intercourse: a case report. Front Med. 2019; 6: 178.

20. Castelo-Branco C., et al. Management of post-menopausal vaginal atrophy and atrophic vaginitis. Maturitas. 2005; 52 (suppl 1): S46-52.

21. Cerdo T., et al. Probiotic, prebiotic, and brain development. Nutrients. 2017; 9 (11): 1247.

22. Chee W.J.Y., Chew S.Y., Than L.T.L. Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health. Microb Cell Fact. 2020; 19 (1): 203.

23. Cheng Y., Ling Z., Li L. The intestinal microbiota and colorectal cancer. Front Immunol. 2020; 11: 615056.

24. Cho C.E., Norman M. Cesarean section and development of the immune system in the offspring. Am J Obstet Gynecol. 2013; 208 (4): 249-54.

25. Clarke G., et al. Minireview: gut microbiota: the neglected endocrine organ. Mol Endocrinol. 2014; 28 (8): 1221-38.

26. Cribby S., Taylor M., Reid G. Vaginal microbiota and the use of probiotics. Interdiscip Perspect Infect Dis. 2008; 2008: 256490.

27. Ding H.T., Taur Y., Walkup J.T. Gut microbiota and autism: key concepts and findings. J Autism Dev Disord. 2017; 47 (2): 480-489.

28. Dominguez-Bello M.G., et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA. 2010; 107 (26): 11 971-5.

29. Dominguez-Bello M.G., et al. Partial restoration of the microbiota of cesarean-born infants via vaginal microbial transfer. Nat Med. 2016; 22 (3): 250-3.

30. Donders G.G., Zodzika J., Rezeberga D. Treatment of bacterial vaginosis: what we have and what we miss. Expert Opin Pharmacother. 2014; 15 (5): 645-57.

31. Evans J.M., Morris L.S., Marchesi J.R. The gut microbiome: the role of a virtual organ in the endocrinology of the host. J Endocrinol. 2013; 218 (3): R37-47.

32. FAO and WHO Working Group Guidelines for the evaluation of probiotics in food. In: Guidelines for the Evaluation of Probiotics in Food. 2002.

33. FDA GRAS Notice 845 for Lactobacillus rhamnosus LGG. FDA, 2019: 83.

34. Franasiak J.M., Scott R.T. Reproductive tract microbiome in assisted reproductive technologies. Fertil Steril. 2015; 104 (6): 1364-71.

35. Gagliardi A., et al. Rebuilding the gut microbiota ecosystem. Int J Environ Res Public Health. 2018; 15 (8): 1679.

36. Gibson G.R., et al. Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 2017; 14 (8): 491-502.

37. Gueimonde M., et al. Effect of maternal consumption of Lactobacillus GG on transfer and establishment of fecal bifidobacterial microbiota in neonates. J Pediatr Gastroenterol Nutr. 2006; 42 (2): 166-170.

38. Gurung M., et al. Role of gut microbiota in type 2 diabetes pathophysiology. EBioMedicine. 2020; 51: 102590.

39. Harper A., et al. Viral infections, the microbiome, and probiotics. Front Cell Infect Microbiol. 2021; 10: 596166.

40. Ho M., et al. Oral Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 to reduce Group B Streptococcus colonization in pregnant women: a randomized controlled trial. Taiwan J Obstet Gynecol. 2016; 55 (4): 515-8.

41. Holmes E., et al. Human metabolic phenotype diversity and its association with diet and blood pressure. Nature. 2008; 453 (7193): 396-400.

42. Holscher H.D. Dietary fiber and prebiotics and the gastrointestinal microbiota. Gut Microbes. 2017; 8 (2): 172-84.

43. Huang H., Song L., Zhao W. Effects of probiotics for the treatment of bacterial vaginosis in adult women: a meta-analysis of randomized clinical trials. Arch Gynecol Obstet. 2014; 289 (6): 1225-34.

44. Jazani N., et al. Impact of gut dysbiosis on neurohormonal pathways in chronic kidney disease. Diseases. 2019; 7 (1): 21.

45. Kalliomaki M., et al. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol. 2007; 119 (4): 1019-21.

46. Kang H.J., Im S.H. Probiotics as an immune modulator. J Nutr Sci Vitaminol. 2015; 61: S103-5.

47. Kaur H., et al. Crosstalk between female gonadal hormones and vaginal microbiota across various phases of women's gynecological lifecycle. Front Microbiol. 2020; 11: 551.

48. Khanna S., Raffals L.E. The microbiome in Crohn's disease: role in pathogenesis and role of microbiome replacement therapies. Gastroenterol Clin North Am. 2017; 46 (3): 481-92.

49. Krauss-Silva L., et al. A randomised controlled trial of probiotics for the prevention of spontaneous preterm delivery associated with bacterial vaginosis: preliminary results. Trials. 2011; 12: 239.

50. Kukkonen K., et al. Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial. Pediatrics. 2008; 122 (1): 8-12.

51. Lazar V., et al. Aspects of gut microbiota and immune system interactions in infectious diseases, immunopathology, and cancer. Front Immunol. 2018; 9: 1830.

52. Ledingham K., Hinchliffe S., Jackson M. Cultural contexts of health and well-being. Antibiotic resistance: integrating cultural contexts of health in addressing the global health problem. WHO, 2019: 84 p

53. Othman M., Neilson J.P., Alfirevic Z. Probiotics for preventing preterm labour. Cochrane Database Syst Rev. 2007; 1: CD005941.

54. Makki K., et al. The impact of dietary fiber on gut microbiota in host health and disease. Cell Host Microbe. 2018; 23 (6): 705-15.

55. Maldonado Galdeano C., et al. Beneficial effects of probiotic consumption on the immune system. Ann Nutr Metab. 2019; 74 (2): 115-24.

56. Marchesi J.R., Ravel J. The vocabulary of microbiome research: a proposal. Micro-biome. 2015; 3 (1): 31.

57. Martinez R.C.R., et al. Improved cure of bacterial vaginosis with single dose of tini-dazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial. Can J Microbiol. 2009; 55 (2): 133-8.

58. Martinez R.C.R., et al. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14. Lett Appl Microbiol. 2009; 48 (3): 269-74.

59. Marziali G., et al. In-vitro effect of vaginal lactobacilli against group B Streptococcus. Microb Pathog. 2019; 136: 103692.

60. Mezzasalma V., et al. Orally administered multispecies probiotic formulations to prevent uro-genital infections: a randomized placebo-controlled pilot study. Arch Gynecol Obstet. 2017; 295 (1): 163-72.

61. Morelli L., et al. Utilization of the intestinal tract as a delivery system for urogenital probiotics. J Clin Gastroenterol. 2004; 38 (6): S107-10.

62. Moscicki A.B., et al. Cervical-vaginal microbiome and associated cytokine profiles in a prospective study of HPV 16 acquisition, persistence, and clearance. Front Cell Infect Microbiol. 2020; 10: 569022.

63. Nappi R.E., Kokot-Kierepa M. Vaginal Health: Insights, Views & Attitudes (VIVA) -results from an international survey. Climacteric. 2012; 15 (1): 36-44.

64. Needell J.C., Zipris D. The role of the intestinal microbiome in type 1 diabetes pathogenesis. Curr Diabetes Rep. 2016; 16 (10): 89.

65. Noyes N., et al. Associations between sexual habits, menstrual hygiene practices, demographics and the vaginal microbiome as revealed by Bayesian network analysis. PLoS One. 2018; 13 (1): e0191625.

66. Palacios S. Managing urogenital atrophy. Maturitas. 2009; 63 (4): 315-8.

67. Parma M., et al. The role of vaginal Lactobacillus Rhamnosus (Normogin®) in preventing bacterial vaginosis in women with history of recurrences, undergoing surgical menopause: a prospective pilot study. Eur Rev Med Pharmacol Sci. 2013; 17 (10): 1399-403.

68. Perez-Brocal V., Latorre A., Moya A. Symbionts and pathogens: what is the difference? Curr Top Microbiol Immunol. 2013; 358: 215-43.

69. Petricevic L., et al. Randomized, double-blind, placebo-controlled study of oral lactobacilli to improve the vaginal flora of postmenopausal women. Eur J Obstet Gynecol Reprod Biol. 2008; 141 (1): 54-7.

70. Quaranta G., Sanguinetti M., Masucci L. Fecal microbiota transplantation: a potential tool for treatment of human female reproductive tract diseases. Front Immunol. 2019; 10: 2653.

71. Reid G., et al. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol Med Microbiol. 2001; 32 (1): 37-41.

72. Reid G., et al. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol. 2003; 35 (2): 131-4.

73. Reid G. Cervicovaginal microbiomes-threats and possibilities. Trends Endocrinol Metab. 2016; 27 (7): 446-54.

74. Riviere A., et al. Bifidobacteria and butyrate-producing colon bacteria: importance and strategies for their stimulation in the human gut. Front Microbiol. 2016; 7: 979.

75. Rosenberg E., DeLong E.F., Thompson F., Lory S., Stackebrandt E., et al. The Prokaryotes: Human Microbiology. In: E. Rosenberg et al. (eds). Berlin; Heidelberg: Springer-Verlag, 2013: 554 p.

76. Sanders M.E., et al. Safety assessment of probiotics for human use. Gut Microbes. 2010; 1 (3): 164-85.

77. Sherman D., et al. Characteristics of normal lochia. Am J Perinatol. 1999; 16 (8): 399-402.

78. Staude B., et al. The microbiome and preterm birth: a change in paradigm with profound implications for pathophysiologic concepts and novel therapeutic strategies. Biomed Res Int. 2018; 2018: 7218187.

79. Tachedjian G., et al. The role of lactic acid production by probiotic Lactobacillus species in vaginal health. Res Microbiol. 2017; 168 (9-10): 782-92.

80. Tester R., Al-Ghazzewi F.H. Intrinsic and extrinsic carbohydrates in the vagina: a short review on vaginal glycogen. Int J Biol Macromol. 2018; 112: 203-6.

81. Thursby E., Juge N. Introduction to the human gut microbiota. Biochem J. 2017; 474 (11): 1823-36.

82. Ursell L.K., et al. Defining the human microbiome. Nutr Rev. 2012; 70 (1): S38.

83. Vandevusse L., Hanson L., Safdar N. Perinatal outcomes of prenatal probiotic and prebiotic administration: an integrative review. J Perinat Neonatal Nurs. 2013; 27 (4): 288-301.

84. Vieira A.T., et al. Influence of oral and gut microbiota in the health of menopausal women. Front Microbiol. 2017; 8: 1884.

85. Vitali B., et al. Dietary supplementation with probiotics during late pregnancy: outcome on vaginal microbiota and cytokine secretion. BMC Microbiol. 2012; 12: 236.

86. Vrese M. de, et al. Impact of oral administration of four lactobacillus strains on Nugent score - systematic review and meta-analysis. Benef. Microbes. 2019; 10 (5): 483-96.

87. Wei W., et al. Microbiota composition and distribution along the female reproductive tract of women with endometriosis. Ann Clin Microbiol Antimicrob. 2020; 19 (1): 15.

88. Wei W., et al. Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome. World J Gastroenterol. 2020; 26 (45): 7153-72.

89. Wells J.M. Immunomodulatory mechanisms of lactobacilli. Microb Cell Fact. 2011; 10 (1): S17.

90. Witkin S.S., Linhares I.M. Why do lactobacilli dominate the human vaginal microbiota? BJOG. 2017; 124 (4): 606-11.

91. Yang Q., et al. Role of dietary nutrients in the modulation of gut microbiota: a narrative review. Nutrients. 2020; 12 (2): 381.

92. Zhang G.Q., et al. Probiotics for prevention of atopy and food hypersensitivity in early childhood A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2016; 95 (8): e2563.

93. Zhang Y.J., et al. Impacts of gut bacteria on human health and diseases. Int J Mol Sci. 2015; 16 (4): 7493-519.

94. Zheng D., Liwinski T., Elinav E. Interaction between microbiota and immunity in health and disease. Cell Res. 2020; 30 (6): 492-506.

95. Abdrakhmanov A.R., Petrova A.S., Abdrakhmanov R.M. Changes in the cellular homeostasis of the cervix tissues, associated with opportunistic sexually transmitted infections. Sovremennye problemy nauki i obrazovaniya [Modern Problems of Science and Education]. 2018; (5): 90. (in Russian)

96. Apolikhina I.A., Gorbunova E.A. Clinical and morphological aspects of vulvovaginal atrophy. Meditsinskiy sovet [Medical Council]. 2014; (9): 110-7. (in Russian) DOI: https://doi.org/10.21518/2079-701X-2014-9-110-117 (in Russian)

97. Ardatskaya M.D. Probiotics, prebiotics and metabiotics in the management of microecological bowel disorders. Meditsinskiy sovet [Medical Council]. 2015; (13): 94-9. DOI: https://doi.org/10.21518/2079-701X-2015-13-94-99 (in Russian)

98. Astashkina A.P. Up to day review the biological feature of bifidobacterium and lactobacillus. Vestnik VGU. Seriya: Khimiya. Biologiya. Farmatsiya [Proceedings of Voronezh State University. Series: Chemistry. Biology. Pharmacy]. 2010; (1): 133-9. (in Russian)

99. Badretdinova F.F., Glebova N.N., Korotkova L.A., Khasanov A.G., Trubin V.B. Obstetric trauma and cicatricial deformity of the cervix. Some controversial issues of the problem (literature review). Nauchnoe obozrenie. Meditsinskie nauki [Scientific Review. Medical Sciences]. 2016; (5): 23-31. (in Russian)

100. Bayramova G.R., Andreev А.О., Dobrovol'skaya D.A., Peremykina A.V. Violation of vaginal microbiocenosis and ways of its correction: interaction of science and practice. Akusherstvo i ginekologiya: novosti, mneniya, obuchenie [Obstetrics and Gynecology: News, Opinions, Training]. 2021; 9 (1): 44-51. DOI: https://doi.org/10.33029/2303-9698-2021-9-1-44-51 (in Russian)

101. Bayramova G.R., Amirkhanyan A.S., Chernova V.F. Vulvovaginal candidiasis: pathogenesis, diagnosis, and treatment strategy. Doktor.Ru [Doctor.Ru]. 2018; 10 (154): 32-6. DOI: https://doi.org/10.31550/1727-2378-2018-154-10-32-36 (in Russian)

102. Bril Yu.A. Leader bet. Oral probiotics: a promising solution to gestational and neonatal problems. StatusPraesens. Ginekologiya. Akusherstvo. Besplodnyy brak [StatusPraesens. Gynecology. Obstetrics. Fruitless marriage]. 2019; 1 (54): 67-72. (in Russian)

103. Voroshilina E.S., Zornikov D.L., Plotko E.E. Correction of vaginal dysbiosis with cavi-tated solution of chlorhexidine in the 1st trimester of pregnancy: effectiveness and safety. Zhurnal akusherstva i zhenskikh bolezney [Journal of Obstetrics and Women's Diseases]. 2014; 63 (5): 29-37. DOI: https://doi.org/10.17816/JOWD63529-37 (in Russian)

104. Glazunova A.V., Yureneva S.V. Vaginal atrophy: etiological aspects and modern approaches of therapy. Lechashchiy vrach [Attending Physician]. 2014; (3): 57-62. (in Russian)

105. Goreva E.A., Petrenko A.V. Prebiotics as functional food ingredients. Nepreryvnoe meditsinskoe obrazovanie i nauka [Continuing Medical Education and Science]. 2015; 10 (1): 32-6. (in Russian)

106. Dadaeva D.G. Vaginal microbiocenosis in the prenatal and postnatal periods. Zhurnal akusherstva i zhenskikh bolezney [Journal of Obstetrics and Women's Diseases]. 2019; 68 (4): 35-45. DOI: https://doi.org/10.17816/JOWD68435-45 (in Russian)

107. Dikke G.B. “Doderlein's lactobacteriosis”, or cytolytic vaginosis, - terra incognita. Akusherstvo i ginekologiya segodnya [Obstetrics and Gynecology Today]. 2020; 8 (4): 6. (in Russian)

108. Ermakova E.I. Genitourinary menopausal syndrome: diagnosis and treatment principles. Meditsinskiy sovet [Medical Council]. 2019; (13): 106-11. DOI: https://doi.org/10.21518/2079-701X-2019-13-106-111 (in Russian)

109. Karpeev S.A., Grinevich V.B., Karpeeva Yu.S., Balukova E.V. Changes in intestinal microbiocenosis with recurrent miscarriage. Gastroenterologiya Sankt-Peterburga [Gastroenterology of Saint Petersburg]. 2017; (1): 82-7. (in Russian)

110. Kravchenko M.E. Nature of vaginal microbiocenosis and correction of various clinical forms of its disorders in girls during puberty: Diss. Saint-Petersburg, 2003. (in Russian)

111. Nagornaya V.F. Rational choice of probiotics for the treatment of vaginal infections. Zdorov'e zhenshchiny [Woman's Health]. 2010; 9 (55): 3-7. (in Russian)

112. Nazarenko L.G., Solovyova N.P. The use of oral probiotics as an alternative clinical strategy for the prevention of obstetric and perinatal infections. Zdorov'e zhenshchiny [Woman's Health]. 2013; 6 (82): 91-6. (in Russian)

113. Nebyshynets L.M., Tesakova M.L., Hrudnitskaya E.N., Harbuzova E.I. The rationale and experience of using probiotics for the treatment of diseases of the genitourinary system. Meditsinskie novosti [Medical News]. 2017; (6): 39-42. (in Russian)

114. Neznanov N.G., Leonova L.V., Rukavishnikov G.V., Kasyanov E.D., Mazo G.E. Enteric microbiota as a research object in mental disorders. Uspekhi fiziologicheskikh nauk [Advances in Physiological Sciences]. 2021; 52 (1): 64-76. (in Russian)

115. Nikolaeva I.V., Tsaregorodtsev A.D., Shaykhieva G.S. Formation of the intestinal microbiota of children and the factors that influence this process. Rossiyskiy vestnik perina-tologii i pediatrii [Russian Bulletin of Perinatology and Pediatrics]. 2018; 63 (3): 13-8. DOI: https://doi.org/10.21508/1027-4065-2018-63-3-13-18 (in Russian)

116. Nikonova E.L., Popova E.N. Microbiota. Moscow, 2019: 256 p. (in Russian)

117. Novikova S.V., Logutova L.S., Ignat'eva M.A. Clinical evaluation of the efficacy and safety of the use of vagilac to treat bacterial vaginosis in pregnancy. Meditsinskiy sovet [Medical Council]. 2018; (13): 90-4. DOI: https://doi.org/10.21518/2079-701X-2018-13-90-94 (in Russian)

118. Ovchinnikova N.V. Surgical treatment for patients with benign concomitant diseases of the cervix uteri. Rossiyskiy vestnik akushera-ginecologa [Russian Bulletin of Obstetrician-Gynecologist]. 2011; 11 (6): 41-6. (in Russian)

119. Osipenko E. D. Microbiocenosis of the vaginal canal in health and disease and its probiotic correction. Zdorov'e zhenshchiny [Woman's Health]. 2012; 10 (76): 52-5. (in Russian)

120. Plotnikova E.Yu., et al. Effect of probiotics on prenatal programming of the baby's microbiota. Akusherstvo i ginekologiya [Obstetrics and Gynecology]. 2019; (9): 174-80 (in Russian)

121. Plotnikova E.Yu., Zakharova Yu.V. Probiotics during pregnancy and lactation: what is the use? RMZh [Russian Medical Journal]. 2015; (17): 1038-43. (in Russian)

122. Podoprigora G.I., Kafarskaya L.I., Baynov N.A., Shkoporov A.N. Bacterial translocation from intestine: microbiological, immunological and pathophysiological aspects. Vestnik RAMN [Bulletin of the Russian Academy of Medical Sciences]. 2015; 70 (6): 640-50. DOI: https://doi.org/10.15690/vramn564 (in Russian)

123. Potapov V.A. Probiotics in gynecology: fashion or aware of the need (market watch). Z turbotoju pro zhinku. 2015: (1): 10-5. (in Russian)

124. Prilepskaya V.N., Kira E.F., Apolikhina I.A., Bayramova G.R., Gomberg M.A., et al. Russian Society of Obstetricians and Gynecologists. Clinical recommendations for the diagnosis and treatment of diseases accompanied by pathological discharge from the genital tract of women. Moscow, 2019: 57 p. (in Russian)

125. Raskina K.V., Martynova E.Yu., Fatkhutdinov I.R., Poteshkin Yu.E. Modern bacteriological agents: the effect on gut microbiota and the role in the treatment of diseases. RMZh [Russian Medical Journal]. 2018; 26 (5-2): 86-91. (in Russian)

126. Rudakova E.B., Zamakhovskaya L. Yu. Correction of vaginal dysbiosis as a way of improving reproductive outcomes for ART programs in patients with missed miscarriage after IVF and ET in anamnesis. Lechashchiy vrach [Attending Physician]. 2016; (3): 29. (in Russian)

127. Sergeeva I.A., Ivanyan A.N., Gustovarova T.A., Krucovsky S.B., Kiracosyan L.S., Bel-skaya G.D., et al. The possibilities of surgical correction of cicatricial-deformed cervix uteri in pregnant women. Vestnik Smolenskoy gosudarstvennoy meditsinskoj akademii [Bulletin of the Smolensk State Medical Academy]. 2017; 16 (1). P. 77-82. (in Russian)

128. Sinyakova A.A., Shipitsyna E.V., Budilovskaya O.V., et al. Anamnestic and microbiological predictors of miscarriage. Zhurnal akusherstva i zhenskikh bolezney [Journal of Obstetrics and Women's Diseases]. 2019; 68(2): 59-70. DOI: https://doi.org/10.17816/JOWD68259-70 (in Russian)

129. Sturov N.V., Popov S.V., Zhukov V.A. Modern approaches to the correction of the gut microbiota. Meditsinskiy sovet [Medical Council]. 2021; (4): 136-43. DOI: https://doi.org/10.21518/2079-701X-2021-4-136-143 (in Russian)

130. Tikhomirov A.L., Sarsania S.I. Compliance in the treatment of vaginal dysbiosis. Meditsinskiy sovet [Medical Council]. 2019; (12): 146-52. DOI: https://doi.org/10.21518/2079-701X-2019-12-146-152 (in Russian)

131. Usenko D.V. Antibiotic-induced changes in the microbiota of the gastrointestinal tract and their correction. RMZh [Russian Medical Journal]. 2018; (2-11): 96-9. (in Russian)

132. Chaplin A.V., Rebrikov D.V., Boldyreva M.N. The human microbiome. Vestnik RGMU [Bulletin of Russian State Medical University]. 2017; (2): 5-13. (in Russian)

133. Chicherin I .Yu., Pogorel'sky I.P., Lundovskikh I.A., Darmov I.V., Gavrilov K.E., Gorshkov A.S., et al. Translocation of the intestinal microbiota. Zhurnal mezhdunarodnoy meditsiny [Journal of International Medicine]. 2016; 19 (2): 87-99. (in Russian)

134. Shikh E. V. New aspects in treatment of vaginal dysbiosis. In: Medical Bulletin: portal of a Russian doctor [Electronic resource]. URL: https://medvestnik.ru/content/inter-views/Novye-aspekty-v-lechenii-vaginalnyh-disbiozov.html (in Russian)

135. Yankovsky D.S., Dyment G.S. Modern aspects of the problem of microecology and dysbiosis. Zdorov'e zhenshchiny [Woman's Health]. 2005; 4 (24): 209-18. (in Russian)

136. Jankovsky D.S., Dyment G.S. Microflora and human health. Kiev: Ekspert LTD, 2008: 552 p. (in Russian)

137. Yarovaya G.A., Blokhina T.B., Neshkova E.A. Diet and intestinal microbiota -is there a connection? In: Scientific Community to promote the clinical study of the human mi-crobiome [Electronic resource]. URL: https://mcrbm.com/articles/racion-pitaniya-i-kishech-naya-mikrobiota---est-li-svyaz/ (in Russian)

138. Microbiota of the Human Body: Implications in Health and Disease. In: A. Schwi-ertz (ed.). 1st ed. Springer, 2016.

139. Antibiotics and microbiota - is feud inevitable? XVIII Russian Congress “Innovative Technologies in Pediatrics and Pediatric Surgery”. Effektivnaya farmakologiya [Effective Pharmacology]. 2019; 15 (43). (in Russian)

140. Pregravid preparation clinical protocol of the Interdisciplinary Association of Reproductive Medicine Professionals (MARS). Moscow: Redaktsiya zhurnala StatusPraesens, 2020: 128 p. (in Russian)

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

CHIEF EDITORS
CHIEF EDITOR
Sukhikh Gennadii Tikhonovich
Academician of the Russian Academy of Medical Sciences, V.I. Kulakov Obstetrics, Gynecology and Perinatology National Medical Research Center of Ministry of Healthсаre of the Russian Federation, Moscow
CHIEF EDITOR
Kurtser Mark Arkadievich
Academician of the Russian Academy of Sciences, MD, Professor, Head of the Obstetrics and Gynecology Subdepartment of the Pediatric Department, N.I. Pirogov Russian National Scientific Research Medical University, Ministry of Health of the Russian Federation
CHIEF EDITOR
Radzinsky Viktor Evseevich
Corresponding Member of the Russian Academy of Sciences, MD, Professor, Head of the Subdepartment of Obstetrics and Gynecology with a Course of Perinatology of the Medical Department in the Russian People?s Friendship University

Journals of «GEOTAR-Media»